Xilio Therapeutics, INC. 4 Filing
Ticker: XLO · Form: 4 · Filed: Apr 16, 2026 · CIK: 0001840233
Sentiment: neutral
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 16, 2026 regarding Xilio Therapeutics, Inc. (XLO). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.